Barriers to Timely Diagnosis of Central Retinal Arterial Occlusions Can Create Hurdles
The key to successful treatment of central retinal arterial occlusions, or CRAOs, is timely recognition of both the symptoms and the systemic severity of the pathology by patients and emergency medical personnel, leading to appropriate treatment with tissue plasminogen activator, or tPA.
“CRAOs are newly characterized as stroke equivalents1 and may benefit from tPA2; however, barriers to presentation and evaluation within the timeframe for tPA administration limit our ability to study potential treatments,” according to Bryce Buchowicz, M.D., from the departments of ophthalmology and neurology at the University of Florida in Gainesville.
In light of this, she and her colleagues undertook an observational study to identify and quantify barriers to timely diagnosis of CRAOs.
Reviewed by UF Health Physicians, Bryce Buchowicz, M.D., Logan Vander Woude, D.O., M.P.H., and Siva S. Iyer, M.D., this Ophthalmology Times article further outlines how the creation of an Adult Emergency Department Monocular Vision Loss Algorithm led to the proposal of a novel protocol to hasten diagnosis, which has been adapted at the UF Health Shands Emergency Room.
View the article “Barriers to Timely Diagnosis of Central Retinal Arterial Occlusions Can Create Hurdles on the Ophthalmology Times."